Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007‐2016. Issue 10 (1st July 2021)
- Record Type:
- Journal Article
- Title:
- Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007‐2016. Issue 10 (1st July 2021)
- Main Title:
- Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007‐2016
- Authors:
- Arshad, Tamoore
Paik, James M.
Biswas, Rakesh
Alqahtani, Saleh A.
Henry, Linda
Younossi, Zobair M. - Abstract:
- Abstract : Understanding the burden of NAFLD among adolescents and young adults has become increasingly relevant. Our aim was to estimate the prevalence of NAFLD among adolescents and young adults in the United States. Data were obtained from National Health and Nutrition Examination Survey from 2007‐2016. Adolescents and young adults aged 12 to 29 years were included. NAFLD was determined by the U.S. Fatty Liver Index in the absence of secondary causes of liver disease, and the differences in prevalence trends were analyzed based on age, gender, and race. Complete data were available for 4, 654 adolescents and young adults (mean age 21 years; 50.9% male; 56.8% White, 20.9% Hispanic, and 13.3% Black). The overall prevalence of NAFLD among adolescents and young adults was 18.5%, ranging from 13.2% among early and middle adolescents (12‐17 years) to 18.7% among late adolescents and young adults (18‐24 years), to 24.0% among older young adults (25‐30 years) (trend P < 0.001). The prevalence of NAFLD was higher for boys than for girls (aged 12‐17: 15.1% vs. 11.3%; aged 18‐24: 21.1% vs. 16.2%; aged 25‐30: 28.7% vs. 19.2%, all P < 0.030). Among all age groups, Hispanics had a higher prevalence of NAFLD than Whites and Blacks (pairwise P < 0.001). Over the study time period, the prevalence of NAFLD among early and middle adolescents and young adults did not change (trend P > 0.80). In contrast, NAFLD prevalence among late adolescents increased (trend P = 0.018). In fact, WhiteAbstract : Understanding the burden of NAFLD among adolescents and young adults has become increasingly relevant. Our aim was to estimate the prevalence of NAFLD among adolescents and young adults in the United States. Data were obtained from National Health and Nutrition Examination Survey from 2007‐2016. Adolescents and young adults aged 12 to 29 years were included. NAFLD was determined by the U.S. Fatty Liver Index in the absence of secondary causes of liver disease, and the differences in prevalence trends were analyzed based on age, gender, and race. Complete data were available for 4, 654 adolescents and young adults (mean age 21 years; 50.9% male; 56.8% White, 20.9% Hispanic, and 13.3% Black). The overall prevalence of NAFLD among adolescents and young adults was 18.5%, ranging from 13.2% among early and middle adolescents (12‐17 years) to 18.7% among late adolescents and young adults (18‐24 years), to 24.0% among older young adults (25‐30 years) (trend P < 0.001). The prevalence of NAFLD was higher for boys than for girls (aged 12‐17: 15.1% vs. 11.3%; aged 18‐24: 21.1% vs. 16.2%; aged 25‐30: 28.7% vs. 19.2%, all P < 0.030). Among all age groups, Hispanics had a higher prevalence of NAFLD than Whites and Blacks (pairwise P < 0.001). Over the study time period, the prevalence of NAFLD among early and middle adolescents and young adults did not change (trend P > 0.80). In contrast, NAFLD prevalence among late adolescents increased (trend P = 0.018). In fact, White and Hispanic late adolescents were the drivers behind this increase in the prevalence of NAFLD. Conclusion: These data indicate an increasing trend in NAFLD prevalence among 18‐24‐year‐olds. These data have important public health and policy implications. Abstract : Over the past decade, the prevalence of NAFLD among the youth (12‐29 years old) is increasing primarily among the 18‐24‐year‐old age group. This increase is partly driven by increases among young Hispanic males. We also found the prevalence of complications of obesity such as insulin resistance and hyperlipidemia parallels that of NAFLD.image … (more)
- Is Part Of:
- Hepatology communications. Volume 5:Issue 10(2021)
- Journal:
- Hepatology communications
- Issue:
- Volume 5:Issue 10(2021)
- Issue Display:
- Volume 5, Issue 10 (2021)
- Year:
- 2021
- Volume:
- 5
- Issue:
- 10
- Issue Sort Value:
- 2021-0005-0010-0000
- Page Start:
- 1676
- Page End:
- 1688
- Publication Date:
- 2021-07-01
- Subjects:
- Hepatology -- Periodicals
Liver -- Diseases -- Periodicals
Liver Diseases
Gastroenterology
Periodicals
Fulltext
Internet Resources
Periodicals
616.36 - Journal URLs:
- http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2471-254X/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/hep4.1760 ↗
- Languages:
- English
- ISSNs:
- 2471-254X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26947.xml